CRB1: one gene, many phenotypes.

Area of Science:

• Ophthalmology
• Genetics
• Molecular Biology

Background:

• Mutations in the CRB1 gene are associated with a spectrum of severe inherited retinal degenerations (IRDs).
• These conditions can manifest as Leber congenital amaurosis, early onset retinal dystrophy, retinitis pigmentosa, or cone-rod dystrophy.
• Early and accurate diagnosis is crucial for managing IRDs and exploring emerging genetic therapies.

Purpose of the Study:

• To highlight key clinical features that suggest CRB1 gene mutations.
• To emphasize the importance of genetic diagnosis in CRB1-related retinal diseases.
• To underscore the potential for gene-targeted therapies in inherited retinal degenerations.

Main Methods:

• Review of clinical presentations associated with CRB1 gene mutations.
• Identification of specific ophthalmological signs indicative of CRB1 disease.
• Discussion of the current understanding of genotype-phenotype correlations.

Main Results:

• Specific clinical signs, including nummular retinal pigmentation, atrophic macula, Coats disease association, and para-arteriolar preservation of the retinal pigment epithelium (PPRPE), are strong indicators of CRB1 disease.
• Retinal degenerations linked with nanophthalmos, hyperopia, or keratoconus also suggest CRB1 mutations.
• A definitive genotype-phenotype relationship for CRB1 mutations remains to be fully established.

Conclusions:

• Ophthalmologists should be aware of these distinctive clinical cues to suspect CRB1 gene involvement.
• Accurate genetic diagnosis of CRB1 disease is essential for patient management and therapeutic strategies.
• Advancements in genetic therapy offer hope for treating CRB1-related retinal degenerations.